CANCER: STATISTICS AND FACTS
Cancer accounts for 8 million deaths per year worldwide
About 1,300,000 new cases of cancer were diagnosed yearly in the US
Every year about 560,000 Americans are expected to die of cancer; more than 1,500 people a day
on the Surveillance, Epidemiology, and End Results (SEER) program
database of the National Cancer Institute, the number of all cancer patients
is expected to more than double from 1.36 million in 2000 to almost 3.0
million in 2050, both due to the aging as well as the growth of the
is the most common malignancy and the second leading cause of cancer
related deaths amongst men in the United States. An estimated
186,000 men were diagnosed with prostate cancer in 2008, and there were
28,660 deaths. In Europe in the same year, there were 190,000 new
cases diagnosed and there were 80,000 prostate cancer related
deaths. The incidence of prostate cancer in Asia is significantly
lower, with the total worldwide burden of prostate cancer thought to be
in the 650,000 to 700,000 range
By 2010, 1.5 million deaths/yr due to lung cancer are projected worldwide.
More than 108,070 people in the United States were diagnosed with colon cancer in 2008 accord to the American Cancer Society. The estimated cancer deaths this year will be 50,000.
Approximately 35,000 Americans are diagnosed each year with
is a serious white blood cell cancer that more than 44,000 Americans
develop every year. Currently there are approximately 218,000 people in
the U.S. living with the disease, and each year 21,000 people die from
affects 38,500 patients each year and the current 5-year survival rate
is about 5%. Pancreas cancer ranks forth in cancer related deaths.
Current therapies for this disease are woefully inadequate. The cost to
provide this ineffective health care is estimated at 4.1 billion
is the most rapidly increasing cancer in the United States, according
to the National Cancer Institute, with more than 62,000 people
diagnosed with the disease annually. Of these, it is estimated that
more than 8,000 will die within three to four years after a form of the
recurrent disease spreads, or metastasizes, to other sites in the body.
The number of new nonmelanoma skin cancer cases in the USA is estimated to be between 900,000 and 1,200,000.
is a B cell malignancy characterized by accumulation of mature clonal
plasma cells in the bone marrow, which leads to progressive bone
destruction and marrow failure. Myeloma is the 2nd most common
hematologic malignancy, with an estimated 19,900 new cases diagnosed
each year and almost 11,000 deaths each year in the US.
Primary kidney cancers
comprise approximately 3.8% of malignancies with an estimated 54,390
new cases and 13,010 deaths in 2008. Additionally, the rate of kidney
cancer has increased over the past 65 years by 2% per year. When
compared to other malignancies, kidney cancer is the seventh most
common cancer diagnosis in men and the ninth most common in women, with
the peak incidence occurring in the sixth decade. Renal cell carcinoma
(RCC) represents 90% of kidney cancers and 30% of persons affected
present with metastatic disease. It has been reported that of these,
85% are clear cell carcinomas with the remaining 15% being papillary,
chromophobe, and collecting duct carcinomas. In Europe, more than 63
000 new cases of renal cell carcinoma and 26 000 deaths were
reported in 2006. Historically, the prognosis for patients with
metastatic RCC has been poor, with a 5-year survival rate of 10%.